Record Number of Bendamustine Abstracts Accepted for Presentation at the ... PR Newswire UK (press release) Two oral and three poster presentations focus on indolent NHL (iNHL) and MCL, comparing treatment with bendamustine-rituximab (B-R) to the standard first-line treatment, CHOP-R/CVP-R. One study demonstrated improved complete response rates and ... |
